Hence, based on this data, 67% TOR on TEAD1, 30–40% decrease in the YAP1-TEAD transcription score, and 60% downregulation of CYR61 protein levels are sufficient to achieve tumor regression in the MPM NCI-H226 model. The gene discussed is TEAD1; the disease is neoplasm.